An Open Label, Single-dose Study to Evaluate the Pharmacokinetics, Metabolism and Excretion Balance of [14C]-ONO-4053 in Healthy Adult Male Subjects

Trial Profile

An Open Label, Single-dose Study to Evaluate the Pharmacokinetics, Metabolism and Excretion Balance of [14C]-ONO-4053 in Healthy Adult Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jun 2014

At a glance

  • Drugs ONO 4053 (Primary)
  • Indications Allergic rhinitis; Seasonal allergic rhinitis
  • Focus Pharmacokinetics
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 14 Apr 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top